These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26408706)

  • 1. Non-covalent Nanocomplexes of Folic Acid and Reducible Polyethylenimine for Survivin siRNA Delivery.
    Zheng B; Yang S; Wang M; Yang X; Teng L; Xie J; Teng L; Lee RJ
    Anticancer Res; 2015 Oct; 35(10):5433-41. PubMed ID: 26408706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
    Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
    Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications.
    Zhong Y; Wang Y; Luo L; Nurhidayah D; Maruf A; Gregersen H; Wu W; Wang GX
    Nanotechnology; 2019 Apr; 30(14):145601. PubMed ID: 30524021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
    Wang J; Dou B; Bao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.
    Teo PY; Yang C; Whilding LM; Parente-Pereira AC; Maher J; George AJ; Hedrick JL; Yang YY; Ghaem-Maghami S
    Adv Healthc Mater; 2015 Jun; 4(8):1180-9. PubMed ID: 25866054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid modified cationic γ-cyclodextrin-oligoethylenimine star polymer with bioreducible disulfide linker for efficient targeted gene delivery.
    Zhao F; Yin H; Zhang Z; Li J
    Biomacromolecules; 2013 Feb; 14(2):476-84. PubMed ID: 23323627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
    Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
    J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.
    Yang S; Yang X; Liu Y; Zheng B; Meng L; Lee RJ; Xie J; Teng L
    Colloids Surf B Biointerfaces; 2015 Nov; 135():274-282. PubMed ID: 26263216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI.
    Liu S; Huang W; Jin MJ; Fan B; Xia GM; Gao ZG
    Eur J Pharm Sci; 2016 Jan; 82():171-82. PubMed ID: 26554721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine.
    Teng L; Xie J; Teng L; Lee RJ
    Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
    Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
    Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
    Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
    Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
    Cheng H; Zhu JL; Zeng X; Jing Y; Zhang XZ; Zhuo RX
    Bioconjug Chem; 2009 Mar; 20(3):481-7. PubMed ID: 19191579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.